SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 30 filers reported holding SURFACE ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -99.9% | 1 | -99.9% | 0.00% | – |
| Q4 2022 | $1,204 | -99.8% | 1,468 | +211.0% | 0.00% | – |
| Q3 2022 | $491,000 | -98.2% | 472 | -97.2% | 0.00% | – |
| Q2 2022 | $27,627,000 | +201.3% | 16,846 | +440.1% | 0.00% | – |
| Q1 2022 | $9,170,000 | -81.3% | 3,119 | -69.6% | 0.00% | – |
| Q4 2021 | $48,981,000 | -21.3% | 10,247 | +24.7% | 0.00% | – |
| Q3 2021 | $62,210,000 | +138.1% | 8,218 | +134.6% | 0.00% | – |
| Q2 2021 | $26,132,000 | +100407.7% | 3,503 | +87475.0% | 0.00% | – |
| Q2 2020 | $26,000 | -78.7% | 4 | -93.8% | 0.00% | – |
| Q1 2020 | $122,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q4 2019 | $122,000 | -94.0% | 65 | -95.5% | 0.00% | – |
| Q3 2019 | $2,029,000 | -49.7% | 1,429 | 0.0% | 0.00% | – |
| Q2 2019 | $4,030,000 | -66.4% | 1,429 | -43.2% | 0.00% | – |
| Q1 2019 | $12,011,000 | +2095.8% | 2,518 | +1851.9% | 0.00% | – |
| Q4 2018 | $547,000 | -79.0% | 129 | -45.8% | 0.00% | – |
| Q3 2018 | $2,604,000 | – | 238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 4,645,453 | $13,100,000 | 14.01% |
| EcoR1 Capital, LLC | 2,312,688 | $6,522,000 | 0.66% |
| NEA Management Company, LLC | 3,315,149 | $9,349,000 | 0.66% |
| BVF INC/IL | 1,021,234 | $2,880,000 | 0.32% |
| Samsara BioCapital, LLC | 78,300 | $221,000 | 0.15% |
| Spark Investment Management LLC | 37,979 | $107,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 94,100 | $265,000 | 0.00% |
| FIL Ltd | 647,317 | $1,825,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 490,750 | $1,384,000 | 0.00% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 10,000 | $28,000 | 0.00% |